COMPLETED

The Impact of Innovative Tax Proposals on Purchase Patterns

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will investigate the effect of four tax proposals (i.e. Tobacco Parity, Nicotine-Content, Harm-Reduction, and Modified Risk Tobacco Product-related taxes) on tobacco product purchasing patterns.

Official Title

ETM Taxes Study 1: The Impact of Innovative Tax Proposals on Purchase Patterns

Quick Facts

Study Start:2023-04-11

Study Completion:2025-06-03

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:COMPLETED

Study ID

NCT05370313

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* provide informed consent * provide a breath carbon monoxide sample ≥ 8 ppm, * be at least 21 years of age (the legal age to purchase tobacco), * smoke at least 10 cigarettes daily, and * use other tobacco products less than weekly.	* report uncontrolled physical or mental health conditions (e.g., uncontrolled diabetes, high blood pressure, major depressive disorder, etc.), * use of smoking cessation medications (e.g., nicotine replacement, bupropion, varenicline) in the past 30 days, * report concrete, immediate plans to alter/quit using their usual tobacco products in the next 30 days, * be pregnant or lactating, or * have plans to move out of the area during the experiment.

Inclusion Criteria

Exclusion Criteria

* provide informed consent
* provide a breath carbon monoxide sample ≥ 8 ppm,
* be at least 21 years of age (the legal age to purchase tobacco),
* smoke at least 10 cigarettes daily, and
* use other tobacco products less than weekly.

* report uncontrolled physical or mental health conditions (e.g., uncontrolled diabetes, high blood pressure, major depressive disorder, etc.),
* use of smoking cessation medications (e.g., nicotine replacement, bupropion, varenicline) in the past 30 days,
* report concrete, immediate plans to alter/quit using their usual tobacco products in the next 30 days,
* be pregnant or lactating, or
* have plans to move out of the area during the experiment.

Contacts and Locations

Principal Investigator

Jeff S Stein, Ph.D.

PRINCIPAL_INVESTIGATOR

Fralin Biomedical Research Institute at VTC

Christine E Sheffer, Ph.D.

PRINCIPAL_INVESTIGATOR

Roswell Park Comprehensive Cancer Center

Study Locations (Sites)

Roswell Park Comprehensive Cancer Center

Buffalo, New York, 14263

United States

Fralin Biomedical Research Institute

Roanoke, Virginia, 24016

United States

Collaborators and Investigators

Sponsor: Virginia Polytechnic Institute and State University

Jeff S Stein, Ph.D., PRINCIPAL_INVESTIGATOR, Fralin Biomedical Research Institute at VTC
Christine E Sheffer, Ph.D., PRINCIPAL_INVESTIGATOR, Roswell Park Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-11

Study Completion Date2025-06-03

Study Record Updates

Study Start Date2023-04-11

Study Completion Date2025-06-03

Terms related to this study

Additional Relevant MeSH Terms

Cigarette Smoking